Description

Balversa (Erdafitinib) is an anticancer agent. It is typically used to treat adults with bladder cancer (urothelial cancer) that has spread or cannot be removed by surgery.

Additional information

Balversa (Erdafitinib) is usually given once daily. However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. Important: Follow the instructions on the label. Do not use more of this product, or more often, than prescribed. If you miss a dose, contact your pharmacist. Administer on empty stomach or with food.

WARNING: People may experience eye problems and vision changes. If you experience changes to your vision such as cloudiness, blurred vision or vision loss, contact your doctor immediately. This medication can cause higher than normal levels of phosphate in the blood. Your doctor will test for the amount of phosphate in your blood with blood tests while you are taking this medication.

In addition to its desired action, this medication may cause some side effects, notably:
It may cause blood in the urine, dry eyes, fever, mouth sores
It may cause dizziness, pale skin, unusual tiredness or weakness, shortness of breath

Contraindications: Hypersensitivity (severe allergy) to any component of the formulation

Taking this medication during pregnancy is contraindicated and harmful for the baby. Women of childbearing potential should use an effective contraceptive method. Pregnant women should not use this product. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor.

A treatment with this medication requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.

Warning

Each person may react differently to a treatment. If you think this medication may be causing side effects (including those described here, or others), talk to your doctor or pharmacist. He or she can help you to determine whether or not the medication is the source of the problem.